Analysts Set Herbalife Nutrition Ltd (HLF) PT at $57.50

Shares of Herbalife Nutrition Ltd (NYSE:HLF) have been assigned a consensus rating of “Buy” from the nine brokerages that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $57.50.

Several equities analysts have weighed in on the stock. Longbow Research lifted their price target on shares of Herbalife Nutrition from $47.14 to $57.00 and gave the company a “buy” rating in a report on Tuesday, March 6th. TheStreet downgraded shares of Herbalife Nutrition from a “b-” rating to a “c” rating in a report on Monday, March 5th. Zacks Investment Research raised shares of Herbalife Nutrition from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a report on Thursday, March 8th. ValuEngine downgraded shares of Herbalife Nutrition from a “hold” rating to a “sell” rating in a report on Wednesday, May 16th. Finally, Citigroup reaffirmed a “neutral” rating and set a $42.50 price target (up previously from $36.50) on shares of Herbalife Nutrition in a report on Thursday, February 22nd.

Herbalife Nutrition traded up $0.64, hitting $53.84, during trading hours on Monday, Marketbeat reports. 6,761 shares of the stock traded hands, compared to its average volume of 2,395,416. The company has a debt-to-equity ratio of -9.63, a current ratio of 2.14 and a quick ratio of 1.78. Herbalife Nutrition has a 1 year low of $30.35 and a 1 year high of $56.74. The company has a market capitalization of $9.37 billion, a P/E ratio of 21.89 and a beta of 1.13.

Herbalife Nutrition (NYSE:HLF) last issued its quarterly earnings results on Thursday, May 3rd. The company reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.14. Herbalife Nutrition had a net margin of 4.68% and a negative return on equity of 1,193.47%. The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.12 billion. During the same quarter in the previous year, the firm earned $0.62 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. sell-side analysts anticipate that Herbalife Nutrition will post 2.67 earnings per share for the current fiscal year.

In other news, EVP Alan L. Hoffman sold 26,157 shares of the business’s stock in a transaction on Monday, May 7th. The shares were sold at an average price of $112.96, for a total value of $2,954,694.72. Following the transaction, the executive vice president now owns 1,882 shares of the company’s stock, valued at $212,590.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Thomas Harms sold 11,393 shares of the business’s stock in a transaction on Wednesday, April 4th. The stock was sold at an average price of $95.98, for a total transaction of $1,093,500.14. The disclosure for this sale can be found here. Insiders sold 10,574,626 shares of company stock worth $557,289,860 in the last three months. Insiders own 6.19% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its holdings in shares of Herbalife Nutrition by 6.0% in the first quarter. Russell Investments Group Ltd. now owns 8,457 shares of the company’s stock worth $824,000 after buying an additional 480 shares in the last quarter. M&T Bank Corp raised its stake in Herbalife Nutrition by 16.8% during the fourth quarter. M&T Bank Corp now owns 6,271 shares of the company’s stock valued at $424,000 after purchasing an additional 900 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Herbalife Nutrition by 36.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,445 shares of the company’s stock valued at $233,000 after purchasing an additional 922 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in Herbalife Nutrition by 1.4% during the fourth quarter. UBS Asset Management Americas Inc. now owns 73,007 shares of the company’s stock valued at $4,944,000 after purchasing an additional 986 shares in the last quarter. Finally, Gideon Capital Advisors Inc. raised its stake in Herbalife Nutrition by 39.1% during the first quarter. Gideon Capital Advisors Inc. now owns 5,014 shares of the company’s stock valued at $489,000 after purchasing an additional 1,409 shares in the last quarter. 45.51% of the stock is currently owned by hedge funds and other institutional investors.

Herbalife Nutrition Company Profile

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Analyst Recommendations for Herbalife Nutrition (NYSE:HLF)

Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply